Provider-reported acceptance and use of the Centers for Disease Control and Prevention messages and materials to support HPV vaccine recommendation for adolescent males

Vaccine

Volumn 34, Issue 35, 2016, Pages 4229-4234

  Scherr, C L ^a   Augusto, B ^b   Ali, K ^b   Malo, T L ^c   Vadaparampil, S T ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c University of North Carolina at Chapel Hill   (United States)

Author keywords

Human papillomavirus; Patient provider communication; Provider recommendation; Reach; Vaccination

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL EVALUATION; CLINICAL PRACTICE; FEMALE; HEALTH CARE UTILIZATION; HEALTH SURVEY; HUMAN; INFECTION PREVENTION; MALE; MIDDLE AGED; PAPILLOMAVIRUS INFECTION; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; PROFESSIONAL KNOWLEDGE; PROGRAM EVALUATION; PUBLIC HEALTH MESSAGE; PUBLIC HEALTH SERVICE; SELF REPORT; THEMATIC ANALYSIS; TREATMENT INDICATION; VACCINATION; WART VIRUS; WEB BROWSER; ATTITUDE TO HEALTH; FLORIDA; GENERAL PRACTITIONER; INFORMATION DISSEMINATION; INTERNET; PAPILLOMAVIRUS INFECTIONS; PEDIATRICIAN; PROCEDURES; QUESTIONNAIRE; STATISTICS AND NUMERICAL DATA; UNITED STATES;

ADOLESCENT; ADULT; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); FEMALE; FLORIDA; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INFORMATION DISSEMINATION; INTERNET; MALE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PEDIATRICIANS; PHYSICIANS, FAMILY; PRACTICE PATTERNS, PHYSICIANS'; SURVEYS AND QUESTIONNAIRES; UNITED STATES;

EID: 84990057784     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2016.06.037     Document Type: Article

References (39)

1. [1] National Center for Chronic Disease Prevention and Health Promotion. Human Papillomavirus (HPV). HPV and Cancer: Centers for Disease Control and Prevention; 2015.
2. [2] Giuliano, A.R., Palefsky, J.M., Goldstone, S., Moreira, E.D. Jr., Penny, M.E., Aranda, C., et al. Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males. N Engl J Med 364 (2011), 401–411.
3. [3] Palefsky, J.M., Giuliano, A.R., Goldstone, S., Moreira, E.D. Jr., Aranda, C., Jessen, H., et al. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med 365 (2011), 1576–1585.
4. [4] Van Damme, P., Olsson, S.E., Block, S., Castellsague, X., Gray, G.E., Herrera, T., et al. Immunogenicity and safety of a 9-valent HPV vaccine. Pediatrics, 2015 peds. 2014–3745.
5. [5] Castellsagué, X., Giuliano, A., Goldstone, S., Guevara, A., Mogensen, O., Palefsky, J., et al. Immunogenicity and safety of the 9-valent HPV vaccine in men. Vaccine 33 (2015), 6892–6901.
6. [6] Petrosky, E., Bocchini, J.A. Jr., Hariri, S., Chesson, H., Curtis, C.R., Saraiya, M., et al. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep 64 (2015), 300–304.
7. [7] Reagan-Steiner, S., Yankey, D., Jeyarajah, J., Elam-Evans, L.D., Singleton, J.A., Curtis, C.R., et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 Years – United States, 2014. MMWR Morb Mortal Wkly Rep 64 (2015), 784–792.
8. [8] CDC. Human papillomavirus (HPV)-associated cancers, by anatomic site and state – United States, 2004–2008 n.d.
9. [9] Gillison, M.L., Chaturvedi, A.K., Lowy, D.R., HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer 113 (2008), 3036–3046.
10. [10] Marty, R., Roze, S., Bresse, X., Largeron, N., Smith-Palmer, J., Estimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in Europe. BMC Cancer, 13, 2013, 10.
11. [11] Holman, D.M., Benard, V., Roland, K.B., Watson, M., Liddon, N., Stokley, S., Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature. JAMA Pediatrics 168 (2014), 76–82.
12. [12] Rickert, V.I., Rehm, S.J., Aalsma, M.C., Zimet, G.D., The role of parental attitudes and provider discussions in uptake of adolescent vaccines. Vaccine 33 (2015), 642–647.
13. [13] Ylitalo, K.R., Lee, H., Mehta, N.K., Health care provider recommendation, human papillomavirus vaccination, and race/ethnicity in the US National Immunization Survey. Am J Public Health 103 (2013), 164–169.
14. [14] Centers for Disease Control and Prevention, National and State Vaccination Coverage among Adolescents Aged 13–17 Years — United States, 2011. MMWR Morb Mortal Wkly Rep 61 (2012), 671–677.
15. [15] Rimer B, Harper, H., Witte, O.N. Accelerating HPV vaccine uptake: urgency for action to prevent cancer. A Report to the President of the United States from the President's Cancer Panel. Bethesda, MD2014.
16. [16] U.S. Department of Health and Human Services, Healthy People 2020. 2014, Office of Disease Prevention and Health Promotion, Washington, DC.
17. [17] Allison, M.A., Hurley, L.P., Markowitz, L., Crane, L.A., Brtnikova, M., Beaty, B.L., et al. Primary care physicians’ perspectives about HPV vaccine. Pediatrics 137 (2016), 1–9.
18. [18] Zimet, G.D., Health care professionals and adolescent vaccination. A call for intervention research. Human Vaccines Immunotherapeutics 10 (2014), 2629–2630.
19. [19] Vadaparampil, S.T., Murphy, D., Rodriguez, M., Malo, T.L., Quinn, G.P., Qualitative responses to a national physician survey on HPV vaccination. Vaccine 31 (2013), 2267–2272.
20. [20] Alexander, A.B., Best, C., Stupiansky, N., Zimet, G.D., A model of health care provider decision making about HPV vaccination in adolescent males. Vaccine, 2015.
21. [21] Stokley, S., Jeyarajah, J., Yankey, D., Cano, M., Gee, J., Roark, J., et al. Human papillomavirus vaccination coverage among adolescents, 2007–2013, and postlicensure vaccine safety monitoring, 2006–2014-United States. MMWR Morb Mortal Wkly Rep 63 (2014), 620–624.
22. [22] Glasgow, R.E., Vogt, T.M., Boles, S.M., Evaluating the public health impact of health promotion interventions: the RE-AIM framework. Am J Public Health 89 (1999), 1322–1327.
23. [23] Vadaparampil ST, Malo TL, Sutton SK, Ali KN, Kahn J, Casler A, et al. Missing the target for routine human papillomavirus vaccination: consistent and strong recommendations are lacking for 11–12 year old males. Under Review.
24. [24] Malo, T.L., Ali, K.N., Sutton, S.K., Perkins, R.B., Giuliano, A.R., Vadaparampil, S.T., The content and context of physicians’ communication with males about human papillomavirus vaccination. Hum Vaccin Immunother, 2016.
25. [25] Cates, J.R., Ortiz, R.R., North, S., Martin, A., Smith, R., Coyne-Beasley, T., Partnering with middle school students to design text messages about HPV vaccination. Health Promotion Practice, 2014 1524839914551365.
26. [26] Hughes, J., Cates, J.R., Liddon, N., Smith, J.S., Gottlieb, S.L., Brewer, N.T., Disparities in how parents are learning about the human papillomavirus vaccine. Cancer Epidemiol Biomark Prev 18 (2009), 363–372.
27. [27] Brewer, N.T., Fazekas, K.I., Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med 45 (2007), 107–114.
28. [28] Brewer NT, Robert C. Presidents cancer panel: acheiving widespread HPV vaccine Uptake. Bethesda, MD2012.
29. [29] Centers for Disease Control and Prevention, National and state vaccination coverage among adolescents aged 13–17 years–United States, 2011. MMWR Morb Mortal Wkly Rep 61 (2012), 671–677.
30. [30] Taylor, J.L., Aalsma, M.C., Gilbert, A.L., Hensel, D.J., Rickert, V.I., Perspectives of family medicine physicians on the importance of adolescent preventive care: a multivariate analysis. BMC Family Practice, 17, 2016, 1.
31. [31] Bynum, S.A., Malo, T.L., Lee, J.-H., Guiliano, A.R., Vadaparampil, S.T., HPV vaccine information-seeking behaviors among US physicians: government, media, or colleagues?. Vaccine 29 (2011), 5090–5093.
32. [32] American Academy of Family Physicians, Strong recommentdation to vaccinate against HPV is key to boosting uptake: Reassure parents that vaccine is safe, effective, important. 2014, AAFP News.
33. [33] Hofstetter, A.M., Rosenthal, S.L., Factors impacting HPV vaccination: lessons for health care professionals. Expert Review Vaccines 13 (2014), 1013–1026.
34. [34] Perkins, R.B., Clark, J.A., Providers’ attitudes toward human papillomavirus vaccination in young men challenges for implementation of 2011 recommendations. Am J Men's Health 6 (2012), 320–323.
35. [35] Kahn, J.A., Rosenthal, S.L., Tissot, A.M., Bernstein, D.I., Wetzel, C., Zimet, G.D., Factors influencing pediatricians’ intention to recommend human papillomavirus vaccines. Ambul Pediatr 7 (2007), 367–373.
36. [36] McRee, A.-L., Gilkey, M.B., Dempsey, A.F., HPV vaccine hesitancy: findings from a statewide survey of health care providers. J Pediatric Health Care 28 (2014), 541–549.
37. [37] Healy, C.M., Montesinos, D.P., Middleman, A.B., Parent and provider perspectives on immunization: are providers overestimating parental concerns?. Vaccine 32 (2014), 579–584.
38. [38] Gilkey, M.B., Moss, J.L., Coyne-Beasley, T., Hall, M.E., Shah, P.D., Brewer, N.T., Physician communication about adolescent vaccination: how is human papillomavirus vaccine different?. Prev Med 77 (2015), 181–185.
39. [39] Alexander, A.B., Stupiansky, N.W., Ott, M.A., Herbenick, D., Reece, M., Zimet, G.D., Parent-son decision-making about human papillomavirus vaccination: a qualitative analysis. BMC Pediatrics, 12, 2012, 192.